ACTIVE

DR PROUMEN OPHTALMOLOGIE

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result664,9 k €+12,1 %over 1 year
Gross margin977,6 k €+25,9 %over 1 year
Equity1,3 M €-5,6 %over 1 year

Identity

Source · BCE/KBO

DR PROUMEN OPHTALMOLOGIE is a Private limited company incorporated in 2021. Its main activity is: Specialist medical practice activities. Its registered office is in Marche-en-Famenne.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0762.666.755
Incorporation
29/01/2021
Legal form
Private limited company
Registered office
Marche, Avenue de la Toison d'Or 156
6900 Marche-en-Famenne · WallonieSee on map
Contributed capital
3 000,00 €
Latest accounts
31/12/2024
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 4 filings

Trend over 4 financial years

2024202320222021
Income statement
Gross margin977,6 k €776,7 k €662,3 k €422,1 k €
EBITDA976 k €775,2 k €659 k €421,8 k €
Operating result946,5 k €756,9 k €657,4 k €421,3 k €
Net result664,9 k €593,3 k €495,4 k €320,4 k €
Balance sheet
Equity1,3 M €1,4 M €818,7 k €323,4 k €
Total assets1,8 M €1,8 M €1,1 M €444,9 k €
Cash632,3 k €51,9 k €1 M €381,8 k €
Debts438,1 k €386,7 k €306,4 k €120,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 2 ended

Active mandates

Xavier PROUMEN

Director

Active

Ended mandates

Xavier PROUMEN

Director · since 29 janvier 2021

Ended
Xavier PROUMEN

Director · since 25 janvier 2021

Ended

Full financial information

Source · NBB
2024202320222021
Type of accountAbridged modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202229/01/2021
Closing of the financial year31/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months
Filing date03/12/202517/07/202405/07/202305/07/2022
General meeting15/06/202529/06/202430/06/202330/06/2022
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 4 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202415/06/202503/12/2025FrenchPDF
Micro model31/12/202329/06/202417/07/2024FrenchPDF
Micro model31/12/202230/06/202305/07/2023FrenchPDF
Micro model31/12/202130/06/202205/07/2022FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 2 ended

Active mandates

Xavier PROUMEN

Director

Active

Ended mandates

Xavier PROUMEN

Director · since 29 janvier 2021

Ended
Xavier PROUMEN

Director · since 25 janvier 2021

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other02/02/2021
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 2024664,9 k €↑
  2. 2023
    Annual accounts 2023593,3 k €↑
  3. 2022
    Annual accounts 2022495,4 k €↑
  4. 2021
    Annual accounts 2021320,4 k €
  5. 29/01/2021
    IncorporationPrivate limited company